Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Diagnostic and Prognostic Value of Non-late Gadolinium Enhancement Cardiac Magnetic Resonance Parameters in Cardiac Amyloidosis — Αlexandros Briasoulis (2022) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Diagnostic and Prognostic Value of Non-late Gadolinium Enhancement Cardiac Magnetic Resonance Parameters in Cardiac Amyloidosis
Shared by
Meletios A Dimopoulos
Diagnostic and Prognostic Value of Non-late Gadolinium Enhancement Cardiac Magnetic Resonance Parameters in Cardiac Amyloidosis
Article
2022
en
Authors
+5 more
ΑB
Αlexandros Briasoulis
NL
Niki Lama
AR
Athanasios Rempakos
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2023
DIAGNOSTIC AND PROGNOSTIC VALUE OF NEWER CARDIAC MAGNETIC RESONANCE PARAMETERS IN PATIENTS WITH CARDIAC AMYLOIDOSIS
Αlexandros Briasoulis
,
Foteini Theodorakakou
,
Athanasios Rempakos
,
Niki Lama
,
Kimon Stamatelopoulos
,
Meletios A Dimopoulos
,
Nikolaos Kelekis
,
Efstathios Kastritis
Article
2022
The utility of splenic imaging parameters in cardiac magnetic resonance for the diagnosis of immunoglobulin light-chain amyloidosis
Niki Lama
,
Αlexandros Briasoulis
,
Efstratios Karavasilis
,
Κimon Stamatelopoulos
,
Angeliki Chasouraki
,
Efthymia Alexopoulou
,
Stavros Spiliοpoulos
,
Foteini Theodorakakou
,
Meletios A Dimopoulos
,
Efstathios Kastritis
,
Nikolaos Kelekis
Article
2018
Sudden cardiac death in athletes and the value of cardiovascular magnetic resonance
Sophie Mavrogeni
,
Flora Bacopoulou
,
Despoina Apostolaki
,
George Chrousos
Article
2010
Diagnostic value of 8.5 T magnetic resonance spectroscopy of benign and malignant skin lesion biopsies
Pascale Guitera
,
Pierrick Bourgeat
,
Jonathan R. Stretch
,
Richard A Scolyer
,
Sébastien Ourselin
,
Cynthia L. Lean
,
John F. Thompson
,
Roger Bourne
Chapter in a book
2001
Correlations between Magnetic Resonance Spectroscopy and Other Magnetic Resonance Parameters in Multiple Sclerosis
Marco Rovaris
,
Massimo Filippi
Discussion(0)
No comments yet. Be the first to comment.